20 results
424B5
NEXI
Neximmune Inc
5 Feb 24
Prospectus supplement for primary offering
4:34pm
candidates into, and successfully complete, clinical trials;
our ability to recruit and enroll suitable patients in our clinical trials;
the timing … ability to recruit and enroll suitable patients in our clinical trials;
the timing or likelihood of the accomplishment of various scientific, clinical
424B5
bd8lc wnv5m7ssqpfkmr
17 Jun 22
Prospectus supplement for primary offering
4:49pm
S-3
wnv09l2g
9 Mar 22
Shelf registration
5:14pm
10-Q
gwv9l qby
17 May 21
Quarterly report
4:14pm
10-K
aupklym
31 Mar 21
Annual report
4:02pm
424B4
oii6j6j
16 Feb 21
Prospectus supplement with pricing info
4:38pm
S-1/A
5mx48o uivl2v
8 Feb 21
IPO registration (amended)
7:29am
S-1
pfmhuesf7b4
19 Jan 21
IPO registration
4:38pm
DRS/A
7tcf5z1i7
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
fggnsiwz tgsx
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next